Patents by Inventor Andrea Zgaga-Griesz

Andrea Zgaga-Griesz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay for clostridium botulinum neurotoxin
    Patent number: 10131933
    Abstract: The present invention relates to materials and methods suitable for determining the presence or amount of Botulinum toxin (BoNT) in a test sample by means of a luminescence assay in which the substrate peptide is composed of: an amino acid sequence susceptible to proteolytic cleavage by BoNT, an amino acid sequence corresponding to a reporter domain encoding a fluorescent or bioluminescent polypeptide, and a tag suitable for attaching the substrate peptide to a suitable support, preferably by covalent bond.
    Type: Grant
    Filed: September 3, 2012
    Date of Patent: November 20, 2018
    Assignee: Albert-Ludwigs-Universitaet Freiburg
    Inventors: Gregory Stevens, Michael Krueger, Andrea Zgaga-Griesz, Gerald Urban, Dalice Silver
  • ASSAY FOR CLOSTRIDIUM BOTULINUM NEUROTOXIN
    Publication number: 20140273039
    Abstract: The present invention relates to a method of determining Botulinum toxin (BoNT) based on a luminescence assay. The present application further relates to a peptide that is susceptible to proteolytic cleavage by BoNT which is suitable for that method.
    Type: Application
    Filed: September 3, 2012
    Publication date: September 18, 2014
    Applicant: ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
    Inventors: Gregory Stevens, Michael Krueger, Andrea Zgaga-Griesz, Gerald Urban, Dalice Silver